Modulation of P-glycoprotein expression in hyperthyroid rat tissues. 2005

Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
Department of Pharmacy, Kyoto University Hospital, Kyoto 606-8507, Japan.

P-glycoprotein (Pgp) is expressed in various normal tissues and plays an important role in drug absorption and disposition. In addition, it is supposed that alterations in the expression levels of Pgp are involved in the inter- and intraindividual variability of pharmacokinetics of many drugs. Since pharmacokinetic properties of various drugs are altered in patients with thyroid disorders, we examined the expression of Pgp and mdr1a/1b mRNA in the kidney, liver, jejunum, and ileum from euthyroid and hyperthyroid rats. Western blot analysis revealed that Pgp expression was markedly increased in the kidney and liver of hyperthyroid rats. In contrast, it was slightly increased in the jejunum and ileum. mdr1a/1b mRNA levels were significantly increased in the kidney of hyperthyroid rats. However, they were not increased in the liver as well as in the jejunum and ileum of hyperthyroid rats. Expression levels of bile salt export pump and mdr2 mRNA were also unchanged in hyperthyroid rat liver. Taken together, these findings suggest that thyroid hormone induces Pgp expression in a tissue-selective manner, and that the modulation of mdr1a/1b mRNA expression in the hyperthyroid state varies among tissues.

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000097202 ATP-Binding Cassette Sub-Family B Member 4 An ATP-binding cassette, sub-family B protein that functions in translocating PHOSPHATIDYLCHOLINES from the inner to the outer leaflet of the canalicular membrane of the HEPATOCYTES. MDR2 Protein,Multidrug Resistance Protein 2,P-Glycoprotein 2,Pgp2 protein,Phosphatidylcholine Translocator ABCB4,2, P-Glycoprotein,ABCB4, Phosphatidylcholine Translocator,ATP Binding Cassette Sub Family B Member 4,P Glycoprotein 2,Translocator ABCB4, Phosphatidylcholine,protein, Pgp2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4

Related Publications

Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
April 1999, Biochemical pharmacology,
Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
February 2002, Hepatology research : the official journal of the Japan Society of Hepatology,
Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
October 1995, Biochemical and biophysical research communications,
Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
February 1994, Carcinogenesis,
Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
February 1998, Biochemical pharmacology,
Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
January 2009, Zeitschrift fur Naturforschung. C, Journal of biosciences,
Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
February 2004, Drug metabolism reviews,
Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
October 2001, The Journal of pharmacology and experimental therapeutics,
Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
January 2010, Methods in molecular biology (Clifton, N.J.),
Naoki Nishio, and Toshiya Katsura, and Kayoko Ashida, and Masahiro Okuda, and Ken-Ichi Inui
January 2020, Expert opinion on drug metabolism & toxicology,
Copied contents to your clipboard!